CS logo
small CS logo
Kirk Barber Research

Calgary, Alberta, Canada
Dermatologist in Calgary, Alberta
1100 1 St SE #510, Calgary, AB T2G 1B1

About Kirk Barber Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Pfizer
4
Innovaderm Research Inc.
3
Amgen
2
Concert Pharmaceuticals
2
Galderma R&D
2
LEO Pharma
2
Abbott
1
Aristea Therapeutics, Inc.
1
Bristol-Myers Squibb
1
Dermira, Inc.
1
Total Rows: 17

Clinical Trials at Kirk Barber Research


During the past decade, Kirk Barber Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 13 clinical trials were completed, i.e. on average, 92.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years330022662211000011115511Started TrialsCompleted Trails20152016201720182019202002468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
2006-10-01
2007-12-01
Completed
1,670
Psoriasis Longitudinal Assessment and Registry
2007-06-21
2030-12-31
Recruiting
16,000
A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis
2001-09-01
2003-07-01
Completed
420
Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy
2008-01-01
2009-04-01
Completed
152
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%
2007-11-01
2008-11-01
Completed
1,075
Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments
2009-09-01
2014-07-01
Completed
89
Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis
2009-11-01
2011-12-01
Completed
870
Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
2010-03-01
2011-11-01
Terminated
33

Rows per page:

1–29 of 29

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kirk Barber Research" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Innovaderm Research Inc." with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Concert Pharmaceuticals" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kirk Barber Research" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Immune Tolerance Network (ITN)" with 1 trials as a collaborator and "Janssen-Ortho LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 4Eli Lilly and Company: 4Pfizer: 4Pfizer: 4Innovaderm Research Inc.: 3Innovaderm Research Inc.: 3Amgen: 2Amgen: 2Concert Pharmaceuticals: 2Concert Pharmaceuticals: 2Galderma R&D: 2Galderma R&D: 2LEO Pharma: 2LEO Pharma: 2Abbott: 1Abbott: 1Aristea Therapeutics, Inc.: 1Aristea Therapeutics, Inc.: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1

Created with Highcharts 11.1.0Top CollaboratorsAmgen: 2Amgen: 2Incyte Corporation: 2Incyte Corporation: 2Immune ToleranceNetwork (ITN): 1Immune ToleranceNetwork (ITN): 1Janssen-Ortho LLC: 1Janssen-Ortho LLC: 1

Clinical Trials Conditions at Kirk Barber Research


According to Clinical.Site data, the most researched conditions in "Kirk Barber Research" are "Psoriasis" (12 trials), "Acne Vulgaris" (4 trials), "Alopecia Areata" (2 trials), "Atopic Dermatitis" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "Kirk Barber Research" in a lesser frequency.

Clinical Trials Intervention Types at Kirk Barber Research


Most popular intervention types in "Kirk Barber Research" are "Drug" (25 trials), "Other" (6 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Apremilast" (2 trials), "Baricitinib" (2 trials), "CP-690,550" (2 trials) and "Ustekinumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Kirk Barber Research


The vast majority of trials in "Kirk Barber Research" are 29 trials for "All" genders.

Clinical Trials Status at Kirk Barber Research


Currently, there are NaN active trials in "Kirk Barber Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Kirk Barber Research, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Kirk Barber Research, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 9Phase 2: 9Phase 1: 3Phase 1: 3Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 23Completed: 23Terminated: 4Terminated: 4Enrolling by invitation: 1Enrolling by invitation: 1Recruiting: 1Recruiting: 1